[Clinical study on Shenning Mixture in treating IgA nephropathy]
- PMID: 11938804
[Clinical study on Shenning Mixture in treating IgA nephropathy]
Abstract
Objective: To study the clinical therapeutic effect of Shenning Mixture (SNM) in treating IgA nephropathy.
Methods: Patients were treated separately with SNM or prednisone by randomized grouping. The criteria, including clinical symptoms, signs, hematuria, albuminuria and immune globulin were observed.
Results: The total effective rate and the complete remission rate in the SNM group were 97.1% and 45.7% respectively, while in the control group, they were 37.1% and 8.6% respectively. Comparison of the two groups showed that the therapeutic effect in the former was better than that in the latter significantly, P < 0.01. The hematuria and albuminuria extenuated and serum IgA lowered more significantly in the SNM group than those in the control group (P < 0.05, P < 0.01).
Conclusion: SNM has obvious therapeutic effect on the hematuria and albuminuria in treating IgA nephropathy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous